SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-090580
Filing Date
2023-08-11
Accepted
2023-08-11 17:01:29
Documents
12
Period of Report
2023-08-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323484d1_8k.htm   iXBRL 8-K 26078
  Complete submission text file 0001104659-23-090580.txt   195531

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scps-20230810.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scps-20230810_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scps-20230810_pre.xml EX-101.PRE 22373
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2323484d1_8k_htm.xml XML 3127
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39788 | Film No.: 231165040
SIC: 2834 Pharmaceutical Preparations